Method and formulations for the therapy of acute renal failure

Details Method and formulations for the therapy of acute renal failure Method and formulations for the therapy of acute renal failure

1993-08-23

1994-11-01

Schain, Howard E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 21, A61K 3736

Patent

active

053607902

ABSTRACT:
The therapy of patients with nephrotoxic or ischemic acute renal failure with epidermal growth factor and/or transforming growth factor-.alpha. is disclosed.

REFERENCES:
patent: 3917824 (1975-11-01), Camble et al.
patent: 3948875 (1976-04-01), Cohen et al.
patent: 4528186 (1985-07-01), Nishimura et al.
patent: 4717717 (1988-01-01), Finkenaur
patent: 4742003 (1988-05-01), Derynck et al.
patent: 4749683 (1988-06-01), Murphy et al.
patent: 4874746 (1989-10-01), Antoniades et al.
patent: 4929442 (1990-05-01), Powell
patent: 4944948 (1990-07-01), Uster et al.
patent: 4959353 (1990-09-01), Brown et al.
patent: 4968673 (1990-11-01), Humphrey
Humes et al., The Journal of Clinical Investigation, Inc., (Dec. 1989) 84:1757-1761.
Coimbra et al., American Physiological Society, (1990) pp. F438-F443.
Reiss et al., Abstract (1989) Convention of Am. Society of Nephrology.
Coimbra et al., Abstract (1989) Convention of Am. Society of Nephrology.
Coimbra et al., Abstract (Not yet dated).
Tsau et al., Abstracts (1989) Kidney Int. 35:420.

Affiliated with

Also associated with

Rating

Method and formulations for the therapy of acute renal failure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and formulations for the therapy of acute renal failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and formulations for the therapy of acute renal failure will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1802553